NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

PRCT

Procept BioRobotics Corp

Jul 11 • 04:00PM ET

56.65

Dollar change -2.56
Percentage change -4.32	%

Healthcare • Medical Devices • USA • NASD

Peers: ISRG MDT ABT SYK BSX EW COO ZBH TFX PODD

| Held by: VTI IWM VB VXF VBK BOTZ IWO IHI SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.70	Insider Own	4.93%	Shs Outstand	55.28M	Perf Week	-2.19%
Market Cap	3.13B	Forward P/E	-	EPS next Y	-1.02	Insider Trans	-6.95%	Shs Float	52.60M	Perf Month	-11.80%
Enterprise Value	2.90B	PEG	-	EPS next Q	-0.41	Inst Own	91.79%	Short Float	12.94%	Perf Quarter	3.60%
Income	-90.19M	P/S	12.58	EPS this Y	13.79%	Inst Trans	0.30%	Short Ratio	7.57	Perf Half Y	-35.28%
Sales	249.12M	P/B	8.05	EPS next Y	32.38%	ROA	-19.99%	Short Interest	6.81M	Perf YTD	-29.64%
Book/sh	7.04	P/C	9.91	EPS next 5Y	35.76%	ROE	-27.62%	52W High	103.81 -45.43%	Perf Year	-13.54%
Cash/sh	5.72	P/FCF	-	EPS past 3/5Y	-8.57% -12.56%	ROIC	-19.31%	52W Low	47.04 20.43%	Perf 3Y	73.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	86.74% 105.21%	Gross Margin	61.67%	Volatility	3.30% 3.48%	Perf 5Y	-
Dividend TTM	-	EV/Sales	11.63	EPS Y/Y TTM	19.87%	Oper. Margin	-38.70%	ATR (14)	2.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.74	Sales Y/Y TTM	59.36%	Profit Margin	-36.20%	RSI (14)	43.88	Recom	1.46
Dividend Gr. 3/5Y	- -	Current Ratio	8.94	EPS Q/Q	11.48%	SMA20	-3.33%	Beta	1.07	Target Price	77.50
Payout	-	Debt/Eq	0.21	Sales Q/Q	55.28%	SMA50	-2.31%	Rel Volume	0.61	Prev Close	59.21
Employees	756	LT Debt/Eq	0.20	Earnings	Apr 24 BMO	SMA200	-19.13%	Avg Volume	899.67K	Price	56.65
IPO	Sep 15, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.24% 5.69%	Trades		Volume	544,694	Change	-4.32%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-09-25	Initiated	Stephens	Overweight	$70
Jul-07-25	Initiated	Oppenheimer	Perform
Dec-02-24	Initiated	Morgan Stanley	Overweight	$105
Nov-14-24	Initiated	Jefferies	Hold	$95
Aug-11-23	Initiated	Piper Sandler	Overweight	$42
May-31-23	Initiated	William Blair	Outperform
Oct-31-22	Initiated	BTIG Research	Neutral
Oct-25-22	Initiated	Truist	Buy	$58
Sep-02-22	Initiated	Wells Fargo	Overweight	$49
Jul-15-22	Initiated	KeyBanc Capital Markets	Overweight	$47
Jun-23-22	Initiated	B. Riley Securities	Buy	$53
Oct-11-21	Initiated	SVB Leerink	Outperform	$46
Oct-11-21	Initiated	Guggenheim	Buy	$45
Oct-11-21	Initiated	Goldman	Neutral	$37
Oct-11-21	Initiated	Cowen	Outperform	$50
Oct-11-21	Initiated	BofA Securities	Buy	$48

Show Previous Ratings

Apr-29-25 04:03PM	PROCEPT BioRobotics to Attend Four Upcoming Investor Conferences in May & June (GlobeNewswire)
Apr-24-25 04:03PM	PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops (GlobeNewswire) -5.64%
02:37PM	PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:15AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (GlobeNewswire)
04:03PM	Loading…
Apr-10-25 04:03PM	PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas (GlobeNewswire) -7.22%
Mar-29-25 06:03PM	PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires (Insider Monkey)
Mar-24-25 08:00AM	WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation Therapy to Laser Enucleation (GlobeNewswire)
Mar-20-25 09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
Mar-14-25 08:00AM	PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada (GlobeNewswire)
Feb-26-25 09:32AM	Q4 2024 Procept Biorobotics Corp Earnings Call (Thomson Reuters StreetEvents) +8.61%
02:15AM	PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Feb-25-25 05:25PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:02PM	PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
01:22AM	PROCEPT BioRobotics Corp (PRCT) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
02:10PM	Loading…
Feb-13-25 02:10PM	Procept BioRobotics Corp. (PRCT): Among the Best Mid-Cap Growth Stocks to Buy According to Analysts (Insider Monkey)
Feb-07-25 08:00AM	PROCEPT BioRobotics to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference (GlobeNewswire)
Jan-16-25 12:00PM	PROCEPT BioRobotics (PRCT) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Dec-28-24 04:59AM	Morgan Stanley Sees Potential Growth in These 2 Surgical Robotic Stocks (TipRanks)
Nov-29-24 11:15AM	PROCEPT BioRobotics Corporation (PRCT) Gains 40% Following Strong Q3 Earnings and Upgraded Guidance (Insider Monkey)
Nov-26-24 04:05PM	PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024 (GlobeNewswire)
Nov-07-24 12:00PM	Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) is a Great Choice (Zacks)
Nov-01-24 02:27PM	These IBD 50 Leaders Melt Gains As Stock Market Wavers (Investor's Business Daily)
Oct-29-24 08:43PM	PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock (GlobeNewswire) +6.25%
12:00PM	All You Need to Know About PROCEPT BioRobotics (PRCT) Rating Upgrade to Strong Buy (Zacks)
11:56AM	Medical Gear Stock Surges Past Buy Point On Upbeat Sales Outlook (Investor's Business Daily)
03:03AM	PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Oct-28-24 05:41PM	Procept BioRobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise (Investor's Business Daily) +32.33%
04:19PM	PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock (GlobeNewswire)
02:17PM	Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential (Benzinga)
11:39AM	Loading…
11:39AM	PROCEPT BioRobotics Jumps 30% Today on Massive Revenue Surge (GuruFocus.com)
08:10AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance (GlobeNewswire)
07:00AM	Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner (PR Newswire)
Oct-25-24 09:35AM	Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT) Looks Ripe for a Turnaround (Zacks)
09:01AM	Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Reports Q3 2024 Result (GuruFocus.com)
Oct-21-24 10:00AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-09-24 04:04PM	PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024 (GlobeNewswire)
Oct-08-24 12:29PM	PROCEPT BioRobotics wins FDA IDE for aquablation trial in prostate cancer (Medical Device Network) +6.29%
Oct-07-24 04:04PM	PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer (GlobeNewswire)
Oct-05-24 06:04PM	PROCEPT BioRobotics Corporation (PRCT) Advances Urology with AI-Integrated HYDROS Robotic System; Price Target Raised to $99 (Insider Monkey)
Sep-25-24 09:01AM	Is Procept Biorobotics Corp. (PRCT) the Worst AI Stock to Buy? (Insider Monkey)
Sep-23-24 09:03AM	Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator? (Insider Monkey) -5.60%
Aug-30-24 05:57AM	Do You Believe in the Growth Prospects of PROCEPT BioRobotics (PRCT)? (Insider Monkey)
Aug-28-24 04:03PM	PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 (GlobeNewswire)
Aug-22-24 01:05PM	PROCEPT BioRobotics' (PRCT) HYDROS System Gets FDA Clearance (Zacks)
09:12AM	PROCEPT (PRCT) Grows in Urology With FDA Clearance for HYDROS (Zacks)
Aug-21-24 07:00AM	PROCEPT BioRobotics Announces FDA Clearance of the HYDROS Robotic System, the Next-Generation, AI-Powered Platform for Aquablation Therapy (GlobeNewswire) +28.36%
Aug-14-24 04:30PM	3 Robotics Stocks to Sell in August Before They Crash & Burn (InvestorPlace)
Aug-01-24 05:50PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -7.45%
04:03PM	PROCEPT BioRobotics Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance (GlobeNewswire)
Jul-15-24 04:03PM	PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024 (GlobeNewswire)
Jun-27-24 04:38PM	You've Been Warned! 3 Robotics Stocks to Buy Now or Regret Forever. (InvestorPlace)
Jun-19-24 02:40AM	Insider Selling: EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics ... (GuruFocus.com)
Jun-17-24 04:03PM	PROCEPT BioRobotics Announces New CPT Category I Code from the American Medical Association for Aquablation therapy (GlobeNewswire)
Jun-03-24 04:03PM	PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024 (GlobeNewswire)
May-17-24 05:20PM	Intuitive Surgical, IBD Stock Of The Day, Feels Its Way Toward Buy Point (Investor's Business Daily)
May-14-24 06:00AM	From Science Fiction to Reality: 3 Robotics Stocks for Automatic Riches (InvestorPlace)
May-13-24 04:05PM	PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference (GlobeNewswire)
May-06-24 09:40AM	Piper Sandler Adjusts Price Target on PROCEPT BioRobotics to $75 From $67, Maintains Overweight Rating (MT Newswires)
08:00AM	Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia (GlobeNewswire)
03:08AM	Procept BioRobotics Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing (MT Newswires)
May-04-24 02:58AM	Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
May-03-24 04:00PM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 08:15AM	Truist Raises PROCEPT BioRobotics' PT to $72 From $63 After 'Solid' Q1 Beat, Keeps Buy Rating (MT Newswires)
May-01-24 03:59PM	Biotech Leader Procept BioRobotics Surges Past Buy Point On Earnings (Investor's Business Daily) +14.40%
01:53PM	PRCT Stock Earnings: PROCEPT BioRobotics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
12:13PM	Procept BioRobotics Shares Rise After Q1 Loss Narrows, Revenue Increases; 2024 Revenue Guidance Revised (MT Newswires)
08:25AM	PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (GlobeNewswire)
Apr-29-24 08:00AM	Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia (GlobeNewswire)
Apr-23-24 08:00AM	PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting (GlobeNewswire) +5.00%
Apr-04-24 04:04PM	PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas (GlobeNewswire)
Apr-02-24 04:03PM	PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024 (GlobeNewswire)
Mar-20-24 07:01PM	PROCEPT BioRobotics Corp (PRCT) President and CEO Reza Zadno Sells Company Shares (GuruFocus.com)
Mar-08-24 01:30AM	EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Mar-06-24 11:55PM	Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Feb-28-24 12:00PM	Q4 2023 Procept Biorobotics Corp Earnings Call (Thomson Reuters StreetEvents)
10:00AM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 04:02PM	PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-20-24 10:00AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-12-24 04:05PM	PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston (GlobeNewswire)
Feb-10-24 02:07AM	EVP, CLO, CORP. SEC. Alaleh Nouri Sells 20,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Feb-08-24 05:30PM	CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors (GlobeNewswire)
Jan-11-24 11:02PM	EVP, CLO, CORP. SEC. Alaleh Nouri Sells 16,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Jan-10-24 03:51AM	Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength? (Zacks)
Jan-08-24 05:00PM	PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million (GlobeNewswire) +15.14%
Dec-16-23 07:02AM	Insider Sell Alert: EVP Alaleh Nouri Divests 15,000 Shares of PROCEPT BioRobotics Corp (GuruFocus.com)
Dec-10-23 01:15AM	Insider Sell Alert: Director Frederic Moll Sells 79,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Dec-09-23 01:05AM	EVP, CFO Kevin Waters Sells 15,085 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Dec-05-23 02:44PM	PROCEPT BioRobotics Stock Scores Rising Relative Strength (Investor's Business Daily)
Nov-15-23 01:03AM	Insider Sell Alert: Director Morgan Wood Sells 25,000 Shares of PROCEPT BioRobotics Corp (PRCT) (GuruFocus.com)
Nov-13-23 04:03PM	PROCEPT BioRobotics to Present at the 35 Annual Piper Sandler Healthcare Conference in New York City (GlobeNewswire)
Nov-06-23 09:55AM	Wall Street Analysts Predict a 25.54% Upside in PROCEPT BioRobotics Corporation (PRCT): Here's What You Should Know (Zacks)
Nov-02-23 04:07PM	PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2023 Earnings Call Transcript (Insider Monkey) +18.37%
09:33AM	Q3 2023 PROCEPT BioRobotics Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 04:02PM	PROCEPT BioRobotics Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance (GlobeNewswire)
Oct-25-23 10:02AM	PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-16-23 04:05PM	PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023 (GlobeNewswire) +9.58%
10:23AM	Wayfair upgraded, JD.com downgraded: Wall Street's top analyst calls (The Fly)

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Desai Antal Rohit	Director	Jun 10 '25	Sale	63.91	25,000	1,597,711	64,363	Jun 12 07:28 PM
Desai Antal Rohit	Director	Jun 11 '25	Sale	63.38	25,000	1,584,525	39,363	Jun 12 07:28 PM
Desai Antal Rohit	Director	Jun 12 '25	Sale	61.49	25,000	1,537,256	14,363	Jun 12 07:28 PM
SHAM SHIBLAQ	Officer	Jun 06 '25	Proposed Sale	64.13	20,000	1,282,638		Jun 06 04:22 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Jun 06 '25	Option Exercise	5.18	20,000	103,600	83,133	Jun 06 04:02 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Jun 06 '25	Sale	64.13	20,000	1,282,637	63,133	Jun 06 04:02 PM
Desai Antal Rohit	Director	Jun 05 '25	Sale	64.79	25,000	1,619,830	89,363	Jun 05 08:05 PM
Desai Antal Rohit	Director	Jun 04 '25	Sale	61.02	25,000	1,525,556	114,363	Jun 05 08:05 PM
Desai Antal Rohit	Director	Jun 03 '25	Sale	60.66	25,000	1,516,475	139,363	Jun 05 08:05 PM
222 DNA TRUST	Director	Jun 03 '25	Proposed Sale	57.94	150,000	8,691,000		Jun 03 04:24 PM
Zadno Reza	President, CEO	May 09 '25	Option Exercise	7.27	13,759	100,028	186,829	May 13 04:59 PM
Zadno Reza	President, CEO	Mar 18 '25	Sale	57.06	5,475	312,404	173,070	Mar 19 04:16 PM
Waters Kevin	EVP, CFO	Mar 18 '25	Sale	57.06	733	41,825	107,991	Mar 19 04:15 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 18 '25	Sale	57.06	247	14,094	63,133	Mar 19 04:08 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 18 '25	Sale	57.06	316	18,031	61,473	Mar 19 04:04 PM
Zadno Reza	Officer	Mar 18 '25	Proposed Sale	57.06	5,475	312,404		Mar 18 07:20 PM
Waters Kevin	Officer	Mar 18 '25	Proposed Sale	57.06	733	41,825		Mar 18 07:07 PM
Shiblaq Hisham	Officer	Mar 18 '25	Proposed Sale	57.06	247	14,094		Mar 18 04:24 PM
Nouri Alaleh	Officer	Mar 18 '25	Proposed Sale	57.06	316	18,031		Mar 18 04:03 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Mar 06 '25	Sale	61.31	3,641	223,230	61,789	Mar 10 04:31 PM
Shiblaq Hisham	EVP, Chief Comm. Officer	Mar 06 '25	Sale	61.31	3,588	219,980	63,380	Mar 10 04:29 PM
Waters Kevin	EVP, CFO	Mar 06 '25	Sale	61.31	3,662	224,517	108,724	Mar 10 04:28 PM
Zadno Reza	President, CEO	Mar 06 '25	Sale	61.31	15,916	975,810	178,545	Mar 10 04:26 PM
Zadno Reza	Officer	Mar 06 '25	Proposed Sale	61.31	15,916	975,735		Mar 06 06:42 PM
Waters Kevin	Officer	Mar 06 '25	Proposed Sale	61.31	3,662	224,500		Mar 06 06:32 PM
Shiblaq Hisham	Officer	Mar 06 '25	Proposed Sale	61.31	3,588	219,963		Mar 06 06:02 PM
Nouri Alaleh	Officer	Mar 06 '25	Proposed Sale	61.31	3,641	223,212		Mar 06 05:49 PM
MOLL FREDERIC H	Director	Feb 10 '25	Option Exercise	1.25	32,012	40,102	841,621	Feb 12 05:39 PM
Zadno Reza	President, CEO	Dec 04 '24	Sale	97.22	26,423	2,568,844	152,762	Dec 06 04:20 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 04 '24	Option Exercise	24.18	28,092	679,336	80,564	Dec 06 04:17 PM
Nouri Alaleh	EVP, CLO, CORP. SEC.	Dec 04 '24	Sale	97.13	28,092	2,728,574	52,472	Dec 06 04:17 PM
REZA ZADNO	Director	Dec 04 '24	Proposed Sale	96.48	26,423	2,549,291		Dec 04 04:36 PM
Alalah Nouri	Officer	Dec 04 '24	Proposed Sale	97.70	56,185	5,489,275		Dec 04 04:10 PM
Zadno Reza	President, CEO	Nov 27 '24	Sale	97.83	26,420	2,584,638	179,185	Dec 02 04:12 PM
REZA ZADNO	Director	Nov 27 '24	Proposed Sale	99.27	26,420	2,622,713		Nov 27 04:35 PM
Zadno Reza	President, CEO	Nov 20 '24	Sale	92.57	26,420	2,445,724	205,605	Nov 22 04:07 PM
REZA ZADNO	Director	Nov 20 '24	Proposed Sale	93.57	26,420	2,472,119		Nov 20 04:29 PM
Zadno Reza	President, CEO	Nov 13 '24	Sale	94.08	26,420	2,485,573	232,025	Nov 15 04:28 PM
REZA ZADNO	Director	Nov 13 '24	Proposed Sale	95.55	26,420	2,524,431		Nov 13 04:23 PM
Desai Antal Rohit	Director	Nov 07 '24	Sale	95.39	34,000	3,243,158	164,363	Nov 07 08:05 PM
Desai Antal Rohit	Director	Nov 06 '24	Sale	97.04	33,000	3,202,444	198,363	Nov 07 08:05 PM
Desai Antal Rohit	Director	Nov 05 '24	Sale	96.60	33,000	3,187,835	231,363	Nov 07 08:05 PM
222 DNA TRUST	Director	Nov 05 '24	Proposed Sale	97.07	100,000	9,707,000		Nov 05 04:23 PM
Zadno Reza	President, CEO	Oct 30 '24	Option Exercise	4.37	288,461	1,260,575	546,906	Oct 31 05:07 PM
Zadno Reza	President, CEO	Oct 30 '24	Sale	91.00	288,461	26,249,951	258,445	Oct 31 05:07 PM
Waters Kevin	EVP, CFO	Oct 15 '24	Option Exercise	4.56	25,000	114,000	121,096	Oct 17 04:27 PM
Waters Kevin	EVP, CFO	Oct 15 '24	Sale	72.47	25,000	1,811,653	96,096	Oct 17 04:27 PM
Waters Kevin	EVP, CFO	Sep 16 '24	Option Exercise	4.53	25,000	113,363	121,096	Sep 18 05:59 PM
Waters Kevin	EVP, CFO	Sep 16 '24	Sale	82.51	25,000	2,062,679	96,096	Sep 18 05:59 PM
Kevin Waters	Affiliate	Sep 16 '24	Proposed Sale	81.11	50,000	4,055,500		Sep 16 05:47 PM
Desai Antal Rohit	Director	Sep 12 '24	Sale	80.11	44,867	3,594,377	197,453	Sep 12 08:03 PM
Desai Antal Rohit	Director	Sep 11 '24	Sale	77.54	38,698	3,000,648	242,320	Sep 12 08:03 PM
Desai Antal Rohit	Director	Sep 10 '24	Sale	76.18	36,500	2,780,570	281,018	Sep 12 08:03 PM
Desai Antal Rohit	Director	Sep 04 '24	Sale	75.42	36,212	2,731,122	330,823	Sep 05 07:13 PM
Desai Antal Rohit	Director	Sep 03 '24	Sale	76.12	35,220	2,680,811	23,963	Sep 05 07:13 PM
Desai Antal Rohit	Director	Sep 04 '24	Sale	75.42	17,420	1,313,876	6,543	Sep 05 07:13 PM
Desai Antal Rohit	Director	Sep 05 '24	Sale	76.37	13,305	1,016,085	317,518	Sep 05 07:13 PM
222 DNA TRUST	Director	Sep 04 '24	Proposed Sale	75.06	169,582	12,728,825		Sep 04 04:16 PM
ANTAL ROHIT DESAI	Director	Sep 03 '24	Proposed Sale	79.00	52,640	4,158,560		Sep 03 04:21 PM
Zadno Reza	President, CEO	Jul 31 '24	Option Exercise	4.37	23,484	102,625	258,445	Aug 23 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRCT

Procept BioRobotics Corp

Upgrade your FINVIZ experience